James M. Hinson

Corporate Officer/Principal at Unicorn Pharma Consulting, Inc.

73 year

Consumer Services

Health Technology

Profile

James M.
Hinson is currently the owner of Unicorn Pharma Consulting, Inc. He was formerly the Chief Medical Officer at Aldagen, Inc. He holds a doctorate degree from Vanderbilt University and an undergraduate degree from the University of Missouri.

James M. Hinson active positions

Companies	Position	Start
Unicorn Pharma Consulting, Inc.	Corporate Officer/Principal	2009-11-05

All active positions of James M. Hinson

Former positions of James M. Hinson

Companies	Position	End
Aldagen, Inc. Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC.	Chief Tech/Sci/R&D Officer	-

See the detail of James M. Hinson's experience

Training of James M. Hinson

Vanderbilt University	Doctorate Degree
University of Missouri	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies